The end of capital-intensive start-ups?

Biotechnology and pharmaceuticals represent the largest sectors for growth and venture investments in Denmark. But as funds become scarce, can these capital-intensive industries survive the downturn? Rikke Lilla Eckhoff takes a closer look at the statistics